UNSPSC 51384521: Dexibuprofen lysine

This classification denotes an ibuprofen analog and nonsteroidal anti-inflammatory agent C13H18O2.C6H14N2O2.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T179MT9211, chemically known as benzeneacetic acid, .alpha.-methyl-4-(2-methylpropyl)-, (s)-, compd. with l-lysine (1:1) monohydrate, but more generally known as dexibuprofen lysine, which bears US NIH Compound Identifier 15009331. Most nations, for tariff and trade purposes, schedule dexibuprofen lysine under HS 29163900 and SITC 51379.

As of Q4 2014, DEXIBUPROFEN LYSINE remains US FDA's Preferred Term for this commodity. SMILES: C[C@@H](C1CCC(CC1)CC(C)C)C(=O)O.C(CCN)C[C@@H](C(=O)O)N.O.

UNSPSC 51384521 Dexibuprofen lysine is a Commodity code for a specific pharmaceutical product, but the single recent state and local opportunity on record does not involve dexibuprofen lysine procurement. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking naloxone and drug deactivation systems—a public health response product unrelated to the code's nominal scope. The mismatch signals either a tagging error in the source data or minimal recent procurement activity under this specific pharmaceutical commodity. State and local governments do not appear to be actively soliciting dexibuprofen lysine through posted competitive bids at present.

Without a relevant recent opportunity, no geographic concentration, issuing-body pattern, or scope characterization can be reliably drawn from current procurement signals.